Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort

doi:10.3748/wjg.v26.i14.1660

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7449)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

525

WORD

158

HTML

3642

Figures (1-5)

392

Tables (1-1)

276

Sum=4993

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

706

Download

1750

Sum=2456

Apr 14, 2020 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Apr 14, 2020; 26(14): 1660-1673
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1660

Full Size Figure Download Figure

Figure 3 Receiver operating characteristic curve generated for the capacity of macrophage inhibitory cytokine-1 or growth differentiation factor-15 to predict solid neoplastic tumours on endoscopic ultrasound (AUC = 0. 793, P = 0.081, n = 3). ROC: Receiver operating characteristic.

Citation: O’Neill RS, Emmanuel S, Williams D, Stoita A. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort. World J Gastroenterol 2020; 26(14): 1660-1673
URL: https://www.wjgnet.com/1007-9327/full/v26/i14/1660.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i14.1660